Biocryst Pharmaceuticals Inc (BCRX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biocryst Pharmaceuticals Inc   (NASDAQ: BCRX)


Biocryst Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biocryst Pharmaceuticals Inc's ROI in the second quarter of 2026?
Biocryst Pharmaceuticals Inc recorded a cumulative net loss of $-385 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -128.98%.

Within the Healthcare sector 561 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3598 to 4171.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -7.38 % 32.84 % 253.13 % - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 349 270 318 256 280
Return On Investment (TTM) -128.98 % -162.99 % 88.36 % -2.91 % -11.09 %
BCRX's Overall Ranking # 4171 # 3598 # 47 # 2615 # 1821
Seq. Investment Change TTM 6.14 % -5.9 % -0.99 % -6.33 % 52.22 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -385 -458 264 -9 -36

BCRX Company Profile >> Back to BCRX Roi Comparisons >> See Annual BCRX Return On Investment



Return On Investment BCRX's Ranking
Within: No.
Industry # 98
Sector # 562
Overall # 4171

Return On Investment Statistics
High Average Low
88.36 %
-105.72 %
-380.87 %
(Dec 31 2025)   (Mar 31 2023)







Financial Statements
Biocryst Pharmaceuticals Inc's II. Quarter Investments $ 349 Millions BCRX's Balance sheet
Biocryst Pharmaceuticals Inc's II. Quarter Income $ 78 Millions Quarterly BCRX's Income Statement
BCRX's Income by Division See BCRX's Income by Division


BCRX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 318 330 -152 -63 484
Y / Y Investment Growth -3.62 % - - - 111.49 %
Net Income in Millions 264 -89 -227 -247 -184
Y / Y Net Income Growth - - - - -
Annual Return On Investment 82.95 % -26.93 % - - -38 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 82.95 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BCRX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BCRX's Competitors
Subscribers only: Roi for Biocryst Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for BCRX's Customers

Other Ratios
BCRX's Roa BCRX's Inventory Turnover Ratio BCRX's Growth Rates BCRX's Dividend Statistics
BCRX's Profitability Ratios BCRX's Asset Turnover Ratio BCRX's Dividend Growth
BCRX's Roe BCRX's Valuation Ratios BCRX's Financial Strength Ratios BCRX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-09T22:24:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.